Palifermin use appears to reduce the severity of oral mucositis in patients receiving high-dose chemotherapy and stem cell transplantation

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2006年 / 1114卷 / 1期
关键词：
Public Health; Stem Cell; Cell Transplantation; Stem Cell Transplantation; Haematological Malignancy;
D O I：
10.2165/00128415-200611140-00010
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4 / 4
相关论文
共 50 条
  • [1] Ability of palifermin to decrease incidence and severity of oral mucositis in patients with haematologic malignancies receiving high-dose chemotherapy conditioning for autologous stem cell transplantation
    Depau, C.
    Baronciani, D.
    Pettinau, M.
    Fanni, A.
    Micheletti, M.
    Drera, M.
    Cattaneo, C.
    Rossi, G.
    Angelucci, E.
    [J]. BONE MARROW TRANSPLANTATION, 2008, 41 : S91 - S92
  • [2] Prevention of oral mucositis with palifermin in patients treated with high-dose chemotherapy and autologous stem cell transplantation. A single center experience.
    Luthi, Francois
    Berwert, Lorenzo
    Frossard, Valerie
    Marchetti, Oscar
    Rosselet, Anne
    Duchosal, Michel
    Ketterer, Nicolas
    [J]. BLOOD, 2006, 108 (11) : 843A - 843A
  • [3] RETROSPECTIVE REVIEW OF THE USE OF PALIFERMIN TO PREVENT MUCOSITIS IN HEMATOPOIETIC STEM CELL TRANSPLANTATION PATIENTS CONDITIONED WITH HIGH-DOSE CHEMOTHERAPY AND TOTAL BODY IRRADIATION
    Kennedy, D.
    Giguere, P.
    Corman, C.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (02) : S318 - S318
  • [4] Glutamine supplementation to reduce oral mucositis in multiple myeloma patients receiving high-dose melphalan and autologous stem cell transplantation: A feasibility study
    Hansen, LK
    Smythe, PA
    Hansen, KS
    Gruenberg, DR
    Callaway, D
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (02) : 144 - 144
  • [5] Polaprezinc Prevents Oral Mucositis in Patients Treated with High-dose Chemotherapy Followed by Hematopoietic Stem Cell Transplantation
    Hayashi, Hiroko
    Kobayashi, Ryo
    Suzuki, Akio
    Ishihara, Masashi
    Nakamura, Nobuhiko
    Kitagawa, Junichi
    Kanemura, Nobuhiro
    Kasahara, Senji
    Kitaichi, Kiyoyuki
    Hara, Takeshi
    Tsurumi, Hisashi
    Moriwaki, Hisataka
    Itoh, Yoshinori
    [J]. ANTICANCER RESEARCH, 2014, 34 (12) : 7271 - 7277
  • [6] Impact of periodontal status on the oral mucositis in patients receiving high-dose chemotherapy
    Sabanci, Arife
    Karasu, Basak
    Sabanci, Halil Ibrahim
    Kuku, Irfan
    Kirmizigul, Omer Alperen
    [J]. CLINICAL ORAL INVESTIGATIONS, 2022, 26 (10) : 6341 - 6346
  • [7] Impact of periodontal status on the oral mucositis in patients receiving high-dose chemotherapy
    Arife Sabancı
    Basak Karasu
    Halil Ibrahim Sabancı
    İrfan Kuku
    Omer Alperen Kırmızıgul
    [J]. Clinical Oral Investigations, 2022, 26 : 6341 - 6346
  • [8] Palifermin for oral mucositis in the high-dose chemotherapy and stem cell transplant setting: the Royal Adelaide Hospital Cancer Centre experience
    Dorothy Keefe
    Jude Lees
    Noemi Horvath
    [J]. Supportive Care in Cancer, 2006, 14 : 580 - 582
  • [9] Palifermin improves oral mucositis after high dose chemotherapy and radiotherapy plus stem cell transplantation in people with haematological cancers
    Clarkson, J
    [J]. CANCER TREATMENT REVIEWS, 2005, 31 (05) : 413 - 416
  • [10] Use of palifermin for the prevention of high-dose methotrexate-induced oral mucositis
    Schmidt, E.
    Thoennissen, N. H.
    Rudat, A.
    Bieker, R.
    Schliemann, C.
    Mesters, R. M.
    Zuehlsdorf, M.
    Mueller-Tidow, C.
    Berdel, W. E.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 (09) : 1644 - 1649
12345